Item 2.02. Results of Operations and Financial Condition.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release, datedMay 4, 2023 , titled "Protagonist Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update." 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
The information in this report, including the exhibit hereto, shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of Section 11 and
12(a)(2) of the Securities Act of 1933, as amended. The information contained
herein and in the accompanying exhibit shall not be incorporated by reference
into any filing with the
© Edgar Online, source